Literature DB >> 21987082

Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare.

Katarina Ilić1, Emil Jakovljević, Vesna Skodrić-Trifunović.   

Abstract

The most prevalent childhood bacterial infections in primary healthcare are respiratory, gastrointestinal and urogenital infections. The main aim of this paper was to consider factors (socio-economic factors and irrational antibiotic use) that contribute to the development of bacterial resistance, as well as measures that resulted in a reduction of this problem. Computerized search through the Medline of published articles on antibiotic resistance from 1996 to 2011 in English or Serbian was completed in August 2011. Combinations of used terms were antimicrobial/antibacterial/antibiotic and resistance/susceptibility in pediatric/children, and Streptococcus pneumoniae/Streptococci/Haemophilus influenzae/Salmonellae/Escherichia coli/Shigella/Staphylococcus aureus as well as antibiotics/antimicrobials/antibacterials and consumption/utilization/use. In many developing countries, antibiotic dispensing and its use in medicine, cattle breeding and agriculture are inadequately regulated, or existing laws are not being appropriately implemented. In addition, human travel contributes to antimicrobial drug resistance around the world. All of these factors have led to a very high level of bacterial resistance. On the contrary, in countries with a clearly defined and implemented legal framework concerning antibiotic prescribing, dispensing and utilization, the use of antibiotics is under constant surveillance. That resulted in a significantly lower antibacterial resistance. In conclusion, bacterial resistance could be reduced by the implementation of systemic and long-term measures at a country level as well as at all levels of healthcare. In order to reduce bacterial resistance, antibiotic use needs to be precisely regulated, and regulations should be coherent with practice. The international community must have a more active role in solving this global problem.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987082     DOI: 10.1007/s00431-011-1592-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  76 in total

Review 1.  Antibiotic resistance: consequences of inaction.

Authors:  S B Levy
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

2.  Antibiotic prescription rates vary markedly between 13 European countries.

Authors:  Sigvard Mölstad; Cecilia Stålsby Lundborg; Anna-Karin Karlsson; Otto Cars
Journal:  Scand J Infect Dis       Date:  2002

3.  Changes in antimicrobial resistance of Escherichia coli causing urinary tract infections in hospitalized children.

Authors:  M Fritzsche; R A Ammann; S Droz; M G Bianchetti; C Aebi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

4.  Antimicrobial resistance patterns and serotype distribution of invasive Streptococcus pneumoniae isolates from children in Taiwan from 1999 to 2004.

Authors:  Wei-Jen Lin; Wen-Tsung Lo; Chen-Ying Chou; Ying-Yan Chen; Shu-Ying Tsai; Mong-Ling Chu; Chih-Chien Wang
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-24       Impact factor: 2.803

Review 5.  Antibiotic pharmacists in the ascendancy.

Authors:  Kieran Hand
Journal:  J Antimicrob Chemother       Date:  2007-08       Impact factor: 5.790

6.  Antibiotic resistance patterns in children hospitalized for urinary tract infections.

Authors:  Stephanie A Lutter; Melissa L Currie; Lindsay B Mitz; Larry A Greenbaum
Journal:  Arch Pediatr Adolesc Med       Date:  2005-10

7.  Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania.

Authors:  E Leibovitz; C Dragomir; S Sfartz; N Porat; P Yagupsky; S Jica; L Florescu; R Dagan
Journal:  Int J Infect Dis       Date:  1999       Impact factor: 3.623

8.  Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan.

Authors:  K Hirose; K Tamura; H Sagara; H Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

9.  Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.

Authors:  Trung Vu Nguyen; Phung Van Le; Chinh Huy Le; Andrej Weintraub
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

10.  Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks.

Authors:  James E Lee; Junelina Reed; Malcolm S Shields; Kathleen M Spiegel; Larry D Farrell; Peter P Sheridan
Journal:  BMC Microbiol       Date:  2007-12-04       Impact factor: 3.605

View more
  16 in total

Review 1.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

2.  Chlorinated metronidazole as a promising alternative for treating trichomoniasis.

Authors:  M O Chacon; T H S Fonseca; S B V Oliveira; M A Alacoque; L L Franco; C A Tagliati; G D Cassali; G P Campos-Mota; R J Alves; L S A Capettini; Maria Aparecida Gomes
Journal:  Parasitol Res       Date:  2018-03-03       Impact factor: 2.289

3.  A one-year prospective study on the antibiotic resistance of E. coli strains isolated in urinary specimens of children hospitalized at the University Pediatric Medical Center in Novi Sad, Serbia.

Authors:  E Jakovljević; K Ilić; Z Jelesić; G Konstantinidis
Journal:  Infection       Date:  2013-07-03       Impact factor: 3.553

4.  Pre-hospital exposures to antibiotics among children presenting with fever in northern Uganda: a facility-based cross-sectional study.

Authors:  Richard Nyeko; Felix Otim; Evelyn Miriam Obiya; Catherine Abala
Journal:  BMC Pediatr       Date:  2022-06-01       Impact factor: 2.567

5.  Daily ingestion of tetracycline residue present in pasteurized milk: a public health problem.

Authors:  Sergio Augusto de Albuquerque Fernandes; Ana Prudencia Assis Magnavita; Sibelli Passini Barbosa Ferrao; Simone Andrade Gualberto; Amanda Santos Faleiro; Abdias Jose Figueiredo; Soraia Vanessa Matarazzo
Journal:  Environ Sci Pollut Res Int       Date:  2013-11-17       Impact factor: 4.223

6.  Incidence and characteristics of bacteremia among children in rural Ghana.

Authors:  Maja Verena Nielsen; Nimako Sarpong; Ralf Krumkamp; Denise Dekker; Wibke Loag; Solomon Amemasor; Alex Agyekum; Florian Marks; Frank Huenger; Anne Caroline Krefis; Ralf Matthias Hagen; Yaw Adu-Sarkodie; Jürgen May; Norbert Georg Schwarz
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

7.  "If it's a broad spectrum, it can shoot better": inappropriate antibiotic prescribing in Cambodia.

Authors:  Chhorvoin Om; Frances Daily; Erika Vlieghe; James C McLaughlin; Mary-Louise McLaws
Journal:  Antimicrob Resist Infect Control       Date:  2016-12-20       Impact factor: 4.887

8.  The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida.

Authors:  Sebastiaan Hermanus Johannes Zegers; Jeanne Dieleman; Tjomme van der Bruggen; Jan Kimpen; Catharine de Jong-de Vos van Steenwijk
Journal:  BMC Infect Dis       Date:  2017-01-12       Impact factor: 3.090

9.  Irrational use of antibiotics in the Moshi Municipality Northern Tanzania: a cross sectional study.

Authors:  Erick Alexander Mboya; Leah Anku Sanga; James Samwel Ngocho
Journal:  Pan Afr Med J       Date:  2018-11-08

10.  Protocol for a pragmatic cluster randomised controlled trial for reducing irrational antibiotic prescribing among children with upper respiratory infections in rural China.

Authors:  Guanyang Zou; Xiaolin Wei; Joseph P Hicks; Yanhong Hu; John Walley; Jun Zeng; Helen Elsey; Rebecca King; Zhitong Zhang; Simin Deng; Yuanyuan Huang; Claire Blacklock; Jia Yin; Qiang Sun; Mei Lin
Journal:  BMJ Open       Date:  2016-05-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.